Mycobacterium leprae

From IDWiki
Revision as of 03:11, 27 November 2019 by Aidan (talk | contribs)

Mycobacterium leprae

Clinical Presentation

  • Incubation period of 3-5 years (with wide range)
  • Classic presentation is anaesthetic hypopigmented skin lesion with thickened nerves
  • Clinical spectrum from tuberculoid, paucibacillary disease to lepromatous, multibacillary disease
    • Paucibacillary (PB) disease has 1 to 5 skin lesions, without bacilli on skin slit smear
    • Multibacillary (MB) disease has more than 5 skin lesions, with or without nerve involvement or bacilli on slit-skin smear (regardless of number of lesions)

Management

Disease Treatment
Paucibacillary 6 months of rifampin, dapsone, and clofazimine
Multibacillary 12 months of rifampin, dapsone, and clofazimine
Rifampin resistance 6 months of at least two second-line drugs with clofazimine, followed by 18 months of one second-line drug with clofazimine
Quinolone resistance As for rifampin resistance, but without a fluoroquinolone

Second-line antibiotics

References

  1. ^  Carl Boodman, Jay Keystone, Isaac I. Bogoch. Leprosy chemoprophylaxis of household contacts: A survey of Canadian infectious disease and tropical medicine specialists. Official Journal of the Association of Medical Microbiology and Infectious Disease Canada. 2021. doi:10.3138/jammi-2021-0017.